Article
Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?
Oncotarget - 7 Jun 2016
Xiao Lin, Yu Xin, Zhang Rong, Chang Hui, Xi Shaoyan, Xiao Weiwei, Zeng Zhifan, Zhang Huizhong, Xu Ruihua, Gao Yuanhong
Abstract excerpt
We sought to determine whether a polymorphism in the Interleukin 13 gene (IL13), 1112 C/T (rs1800925) predicts responsiveness to neoadjuvant chemoradiotherapy (neoCRT) and prognosis in Chinese Han patients with locally advanced rectal cancer (LARC). Pre-treatment biopsies of primary rectal lesion and surgical specimens were collected from 58 patients with LARC, who were treated with neoCRT and surgery. Tumor DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
